Outcomes of aggressive B cell lymphoma patients with no evidence of measurable disease at the time of CD19 chimeric antigen receptor T cell therapy: The experience from the CAR T Cell Consortium Meeting Abstract
| Authors: | Wudhikarn, K.; Tomas, A. A.; Brower, J.; Bachanova, V.; Maziarz, R. T.; McGuirk, J. P.; Nastoupil, L.; Porter, D. L.; Riedell, P. A.; Perales, M. A. |
| Abstract Title: | Outcomes of aggressive B cell lymphoma patients with no evidence of measurable disease at the time of CD19 chimeric antigen receptor T cell therapy: The experience from the CAR T Cell Consortium |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736413903137 |
| DOI: | 10.1182/blood-2021-150012 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 284 -- Hybrid meeting, also took place online -- Source: Wos |
